- Home
- EDU vs CORT Comparison
EDU vs CORT Comparison
Compare EDU & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDU | CORT |
|---|---|---|
| Founded | 1993 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.6B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | EDU | CORT |
|---|---|---|
| Price | $55.91 | $81.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $57.87 | ★ $130.20 |
| AVG Volume (30 Days) | 834.2K | ★ 978.2K |
| Earning Date | 01-20-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.27 | 0.87 |
| Revenue | ★ $4,987,826,000.00 | $741,172,000.00 |
| Revenue This Year | $10.59 | $23.79 |
| Revenue Next Year | $10.33 | $40.97 |
| P/E Ratio | ★ $24.65 | $97.44 |
| Revenue Growth | 7.29 | ★ 17.92 |
| 52 Week Low | $40.66 | $49.00 |
| 52 Week High | $64.38 | $117.33 |
Technical Indicators
Market Signals| Indicator | EDU | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 60.14 | 49.96 |
| Support Level | $55.10 | $78.07 |
| Resistance Level | $56.09 | $85.34 |
| Average True Range (ATR) | 1.04 | 3.56 |
| MACD | 0.42 | -0.39 |
| Stochastic Oscillator | 92.80 | 34.40 |
Price Performance
Historical ComparisonAbout EDU New Oriental Education & Technology Group Inc.
New Oriental Education & Technology is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation and consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.